DUBLIN, June 17, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Microbiology Testing/Clinical Microbiology Market by Microbiology Application, Clinical Application, Product - Global Forecasts to 2021" report to their offering.

The global clinical microbiology market is forecast to reach USD 5.77 Billion by 2021.

On the basis of products, the clinical microbiology market is segmented into instruments and reagents. The instruments segment is expected to account for the larger share of the global market in 2016. The dominant market position of the clinical microbiology instruments segment is mainly due to factors such as the high cost of instruments, significant adoption of conventional laboratory instruments among researchers & academia, technological advancements, and ongoing trend of laboratory automation among clinical laboratories.

However, reagents segment is the faster-growing product category, growing at a double-digit CAGR during 2016 to 2021. Market growth of the reagents segment is propelled by factors such as growing trend of reagent rental agreements (along with instrument sales) by prominent reagent manufacturers, rising private-public funding for researches on specific infectious diseases, increasing market availability of pathogen-specific kits across the globe, and growing demand for specific clinical microbiology reagents during epidemic outbreaks.

On the basis of disease area, the global clinical microbiology market is segmented into respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases (cardiovascular disease, central nervous system infections, connective tissue & joint diseases, and skin diseases, among others). The respiratory diseases segment is expected to account for the largest share of the global market in 2016. This segment is also projected to grow fastest in the global market during 2016-2021. The significant growth potential offered by the respiratory disease segment can be attributed to factors such as the large patient population for respiratory diseases and rising prevalence of tuberculosis across developing countries.

Companies Mentioned:

Abbott Laboratories, Inc.

Alere, Inc.

Becton, Dickinson and Company

Bio-Rad Laboratories Inc.

Biomerieux S.A.

Bruker Corporation

Cepheid (U.S.)

Danaher Corporation

F. Hoffman-LA Roche Ltd.

Hologic, Inc.

Report Structure:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Clinical Microbiology Market, By Product

8 Microbiology Testing Market, By Application

9 Clinical Microbiology Market, By Disease Area

10 Microbiology Testing/Clinical Microbiology Market, By Region

11 Competitive Landscape

12 Company Profiles

13 Appendix

For more information visit http://www.researchandmarkets.com/research/8r62zs/microbiology

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[email protected]

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

